Your browser doesn't support javascript.
loading
A comprehensive and perspective view of oncoprotein SET in cancer.
Bayarkhangai, Buuvee; Noureldin, Suzan; Yu, Liting; Zhao, Na; Gu, Yaru; Xu, Hanmei; Guo, Changying.
Afiliação
  • Bayarkhangai B; State Key of Natural Medicine, China Pharmaceutical University, Nanjing, China.
  • Noureldin S; State Key of Natural Medicine, China Pharmaceutical University, Nanjing, China.
  • Yu L; State Key of Natural Medicine, China Pharmaceutical University, Nanjing, China.
  • Zhao N; State Key of Natural Medicine, China Pharmaceutical University, Nanjing, China.
  • Gu Y; State Key of Natural Medicine, China Pharmaceutical University, Nanjing, China.
  • Xu H; State Key of Natural Medicine, China Pharmaceutical University, Nanjing, China.
  • Guo C; State Key of Natural Medicine, China Pharmaceutical University, Nanjing, China.
Cancer Med ; 7(7): 3084-3094, 2018 Jul.
Article em En | MEDLINE | ID: mdl-29749127
ABSTRACT
SET is a multifunctional oncoprotein which is ubiquitously expressed in all kinds of cells. The SET protein participates in many cellular processes including cell cycle, cell migration, apoptosis, transcription, and DNA repair. Accumulating evidence demonstrates that the expression and activity of SET correlate with cancer occurrence, metastasis, and prognosis. Therefore, the SET protein is regarded as a potential target for cancer therapy and several inhibitors are being developed for clinical use. Herein, we comprehensively review the physiological and pathological functions of SET as well as its structure-function relationship. Additionally, the regulatory mechanisms of SET at both transcriptional and posttranslational levels are also discussed.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cancer Med Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cancer Med Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China